Palm Anna-Karin E, Wilson Patrick C
THE UNIVERSITY OF CHICAGO.
Blood. 2016 Jul 21;128(3):317-8. doi: 10.1182/blood-2016-06-717538.
In this issue of , Bhoj et al explore the longevity of plasma cells (PCs) and humoral immunity in the absence of B cells. This is done by studying subjects experiencing B-cell aplasia after CD19-directed chimeric antigen receptor (CAR) therapy.
在本期杂志中,博杰等人探讨了在没有B细胞的情况下浆细胞(PC)的寿命和体液免疫。这是通过研究接受CD19导向嵌合抗原受体(CAR)治疗后出现B细胞发育不全的受试者来完成的。